Millennium Management
AEON icon

Millennium Management’s AEON Biopharma AEON Stock Holding History

Millennium Management’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-708
Closed -$53.5K – 6043
2024
Q2 		$53.5K Sell
708
-70
-9% -$16.7K ﹤0.01% 5406
2024
Q1 		$649K Buy
+778
New +$563K ﹤0.01% 4628
2023
Q1 		– Sell
-5,056
Closed -$3.66M – 6304
2022
Q4 		$3.66M Sell
5,056
-3,018
-37% -$2.16M ﹤0.01% 3069
2022
Q3 		$5.73M Buy
8,074
+215
+3% +$152K ﹤0.01% 2771
2022
Q2 		$5.55M Sell
7,859
-35
-0.4% -$24.7K ﹤0.01% 2685
2022
Q1 		$5.56M Sell
7,894
-154
-2% -$108K ﹤0.01% 2821
2021
Q4 		$5.63M Buy
8,048
+5,316
+195% +$3.74M ﹤0.01% 2783
2021
Q3 		$1.92M Buy
2,732
+1,444
+112% +$1.01M ﹤0.01% 3979
2021
Q2 		$894K Buy
+1,288
New +$901K ﹤0.01% 4768

Other funds holding AEON

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return

Millennium Management's AEON Position: Q3 2024 in Review

Millennium Management sold out of AEON Biopharma (AEON) in Q3 2024, closing a stake of 708 shares — an estimated $53.5K sold.

Millennium Management first reported a position in AEON in Q2 2021 and held it in 9 quarters. The position peaked at $5.73M in Q3 2022. 30 funds tracked by Wall St. Rank hold AEON as of Q3 2024.

  • Millennium Management reported no remaining AEON Biopharma position as of Q3 2024 after selling out during the quarter.
  • Millennium Management sold 708 AEON Biopharma shares in Q3 2024, an estimated $53.5K.
  • Millennium Management first reported a position in AEON Biopharma in Q2 2021 and held it in 9 quarters.
  • Millennium Management's AEON Biopharma position peaked at $5.73M in Q3 2022.
  • 30 funds tracked by Wall St. Rank held AEON Biopharma as of Q3 2024.

Based on Millennium Management's 13F filing for Q3 2024, filed 14 Nov 2024.